ELI
ALXN

Empire Life Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Empire Life Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-996
Closed -$183K – 106
2021
Q2 		$183K Sell
996
-199,910
-100% -$34.3M 0.01% 100
2021
Q1 		$30.7M Sell
200,906
-93,608
-32% -$14.5M 2.11% 17
2020
Q4 		$46M Sell
294,514
-8,945
-3% -$1.15M 3.25% 7
2020
Q3 		$34.7M Buy
303,459
+937
+0.3% +$101K 2.79% 12
2020
Q2 		$34M Sell
302,522
-2,289
-0.8% -$243K 2.98% 10
2020
Q1 		$27.4M Buy
304,811
+53,607
+21% +$5.26M 2.5% 13
2019
Q4 		$27.2M Buy
251,204
+38,329
+18% +$4.1M 2.07% 20
2019
Q3 		$20.8M Buy
212,875
+115,239
+118% +$13M 1.75% 26
2019
Q2 		$12.8M Buy
97,636
+1,364
+1% +$176K 1.03% 41
2019
Q1 		$13M Sell
96,272
-21,553
-18% -$2.68M 1.09% 41
2018
Q4 		$11.5M Buy
+117,825
New +$13.9M 1.03% 41

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Empire Life Investments's ALXN Position: Q3 2021 in Review

Empire Life Investments sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 996 shares — an estimated $183K sold.

Empire Life Investments first reported a position in ALXN in Q4 2018 and held it in 11 quarters. The position peaked at $46M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Empire Life Investments reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Empire Life Investments sold 996 Alexion Pharmaceuticals shares in Q3 2021, an estimated $183K.
  • Empire Life Investments first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • Empire Life Investments's Alexion Pharmaceuticals position peaked at $46M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Empire Life Investments's 13F filing for Q3 2021, filed 9 Nov 2021.